China Healthcare : Appointment of Executive Director

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

CHINA HEALTHCARE ENTERPRISE GROUP LIMITED

華 夏健 康產 業集團 有 限公 司

(Incorporated in the Cayman Islands with limited liability)

(Stock code: 1143)

APPOINTMENT OF EXECUTIVE DIRECTOR

The Board announces that Mr. Duan Chuanhong has been appointed as an executive Director with effect from 1 June 2017.

The board of directors (the''Directors'') (the''Board'') of China Healthcare Enterprise Group Limited (the''Company'') is pleased to announce that Mr. Duan Chuanhong (''Mr. Duan'') has been appointed as an executive Director with effect from 1 June 2017.

Particulars relating to Mr. Duan are set out below:

Mr. Duan, aged 29, had worked in different industries for over 10 years. Mr. Duan has ample experience in corporate planning, management and execution.

As at the date of this announcement, Mr. Duan has confirmed that he does not hold any directorship in other listed companies, the securities of which are listed on any securities market in Hong Kong or overseas in the last three years. Mr. Duan does not hold any other positions with the Company or other subsidiaries of the Company.

There is no service contract between the Company and Mr. Duan. Mr. Duan is subject to retirement at the first general meeting of the Company after his appointment and thereafter subject to retirement by rotation at least once every three years and in accordance with the memorandum and articles of association of the Company.

The remuneration of Mr. Duan will be determined by the Remuneration Committee and the Board with reference to his duties and responsibilities with the Company as well as prevailing market rates. The respective remuneration is subject to review by the Remuneration Committee and the Board from time to time.

Mr. Duan does not have any relationship with any other directors, senior management or substantial or controlling shareholders (as defined in the Rules (the''Listing Rules'') Governing the Listing of Securities on the Stock Exchange of Hong Kong Limited) of the Company. Further, Mr. Duan does not have, and is not deemed to have, any interests or short positions in any shares, underlying shares or debentures (as defined under Part XV of the Securities and Futures Ordinance, Cap. 571 of Laws of Hong Kong) of the Company.

Save as disclosed above, there are no other matters concerning Mr. Duan that need to be brought to the attention of the shareholders nor is there any information relating to Mr. Duan that is required to be disclosed pursuant to Rules 13.51(2)(h) to (v) of the Listing Rules.

The Board would like to express its warmest welcome to Mr. Duan in joining the Company.

By order of the Board

China Healthcare Enterprise Group Limited Mr. Gong Shaoxiang

Chairman and Executive Director

Hong Kong, 1 June 2017

As at the date of this announcement, the Board comprises Mr. Gong Shaoxiang (Chairman), Mr. Lee Chi Hwa Joshua and Mr. Duan Chuanhong as executive Directors, Mr. Cao Yuyun and Mr. Chan Kin Sang as non-executive Directors and Mr. Bao Jinqiao, Mr. Wong Chun Hung and Mr. Leung Pok Man as independent non-executive Directors.